Publications & Research

Publications: Dr. Carolyn Henry

Weisse C, Soares N, Beal MW, Steffey MA, Drobatz KJ, Henry CJ.  Survival times in dogs with right atrial hemangiosarcoma treated by means of surgical resection with or without adjuvant chemotherapy: 23 cases (1986-2000). J Am Vet Med Assoc. 2005; 226(4):575-79.  [Abstract]

Henry CJ, Buss MS, Hellstrom I, Hellstrom KE, Brewer WG, Bryan JN, Siegall CB.  Clinical evaluation of BR96 sFv-PE40 immunotoxin therapy in canine models of spontaneously occurring invasive carcinoma.  Clin Cancer Res 2005; 11(2 Pt 1):751-55. [Abstract]

Dvorak LD, Beaver DP, Ellison GW, Bellah JR, Mann FA, Henry CJ.  Major glossectomy in dogs: a case series and proposed classification system. J Am Anim Hosp Assoc 2004; 40:331-37. [Abstract]

Bryan JN, Lewis MR, Henry CJ, Owen NK, Zhang J, Mohsin H, Jia F, Sivaguru G, Anderson CJ.  Development of a two-antibody model for the evaluation of copper-64 radioimmunotherapy. Vet Comp Oncol 2004; 2(2):82-90. [Abstract]

Cahalane AK, Payne S, Barber LG, Duda LE, Henry CJ, Mauldin GE, Frimberger AE, Cotter SM, Moore AS.  Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994-2002). J Am Vet Med Assoc 2004; 225(3):401-08. [Abstract]

Henry CJ. Management of transitional cell carcinoma. Vet Clin North Amer: Sm Anim Pract 2003; 33(3):597-613. [Abstract]

Henry CJ, Tyler JW, McEntee MC, Stokol T, Rogers KS, Chun R, Garrett LD, McCaw DL, Higginbotham ML, Flessland KA, Stokes PK. Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs. Am J Vet Res 2003;64(8):1017-20.  [Abstract]

Higginbotham ML, Henry CJ, Katti KV, Casteel SW, Dowling PM, Pillarsetty N. Preclinical tolerance and pharmacokinetic assessment of MU-Gold, a novel chemotherapeutic agent, in laboratory dogs. Vet Ther 2003; 4(1):76-82.  [Abstract]

Henry CJ, McCaw DL, Turnquist SE, Tyler JW, Bravo L, Sheafor S, Straw RC, Dernell WS, Madewell BR, Jorgensen L, Scott MA, Higginbotham ML, Chun R.  Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma. Clin Cancer Res 2003; 9(2):906-11. [Abstract]

Henry CJ, Russell LE, Tyler JW, Buss MS, Sequin B, Cambridge AJ, Moore ME.  Comparison of hematological and biochemical values for blood samples obtained via jugular venipuncture to those obtained via vascular access ports in cats. J Amer Vet Med Assoc 2002; 220(4):482-85.  [Abstract]

Moore AS, Nelson RW, Henry CJ, Rassnick KM, Kristal O, Ogilvie GK, Kintzer P.  Streptozocin for treatment of pancreatic islet cell tumors in dogs: 17 cases (1989-1999).  J Am Vet Med Assoc 2002; 221(6):811-18. [Abstract]

Clifford CA, Hughes D, Beal MW, Mackin AJ, Henry CJ, Shofer FS, Sorenmo KU.  Vascular endothelial growth factor concentrations in body cavity effusions in dogs.  J Vet Intern Med 2002;16(2):164-68.  [Abstract]

Henry CJ, McCaw DL, Brock KV, Stoker AM, Tyler JW, Tate DJ, Higginbotham ML. Association between cancer chemotherapy and cancer distemper virus, canine parvovirus, and rabies virus antibody titers in tumor-bearing dogs. J Am Vet Med Assoc 2001; 219(9):1238-1241.  [Abstract]

Henry CJ, McCaw DL, Buss MS, Pope ER, Tyler JW, Tate D, Russell L.  Clinical assessment of a chemosensitivity assay as a treatment planning tool for dogs with cancer.  J Amer Anim Hosp Assoc 2001; 37(2):165-171.  [Abstract]

Clifford CA, Mackin AJ, Henry CJ.  Treatment of canine hemangiosarcoma: 2000 and beyond.  J Vet Intern Med 2000; 14(5):479-485.  [Abstract]

Buss MS, Henry CJ, Tyler JW, Tobias KS, Daoud S, Hoopes J, Moore MP.  Systemic and tissue chamber fluid platinum concentrations released from cis-diamminedichloroplatinum II-impregnated polymethylmethacrylate in healthy dogs.  Am J Vet Res 1999; 60(3):280-83.  [Abstract]

Henry CJ, Turnquist SE, Smith A, Graham JC, Thamm DH, O'Brien M, Clifford CA. Primary renal tumors in cats: 19 cases (1992-1998).  J Feline Med Surg 1999; 1(3):165-70.  [Abstract]

MacEwen EG, Kurzman ID, Vail DM, Dubielzig RR, Madewell BR, Rodriguez CO, Phillips B, Zwahlen C, Obradovich J, Rosenthal RC, Fox LE, Rosenberg M, Henry CJ, Fidel J.  Adjuvant therapy for melanoma in dogs: Results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.  Clin Cancer Res 1999; 5(12): 4249-58.  [Abstract]

Henry CJ, Brewer WG, Tyler JW, Brawner WR, Henderson RA, Hankes GH, Royer N.  Survival in dogs with nasal adenocarcinoma: 64 cases (1981-1995).  J Vet Intern Med 1998; 12(6):436-39.  [Abstract]